A new dimension in publishing ethics: social media-based ethics-related accusations

Purpose Whistle-blowing, which has become an integral part of the post-publication peer-review movement, is being fortified by social media. Anonymous commenting on blogs as well as Tweets about suspicions of academic misconduct can spread quickly on social media sites like Twitter. The purpose of this paper is to examine two cases to expand the discussion about how complex post-publication peer review is and to contextualize the use of social media within this movement. Design/methodology/approach This paper examines a Twitter-based exchange between an established pseudonymous blogger and science critic, Neuroskeptic , and Elizabeth Wager, the former COPE Chair, within a wider discussion of the use of social media in post-publication peer review. The paper also discusses false claims made on Twitter by another science watchdog, Leonid Schneider. The policies of 15 publishers related to anonymous or pseudonymous whistle-blowing are examined. Findings Four issues in the Neuroskeptic –Wager case were debated: the solicitation by Wager to publish in RIPR; the use of commercial software by Neuroskeptic to make anonymous reports to journals; the links between “publication ethics” leaders and whistle-blowers or pseudonymous identities; the issues of transparency and possible hidden conflicts of interest. Only one publisher (Wiley) out of 15 scientific publishers examined claimed in its official ethical guidelines that anonymous reports should be investigated in the same way as named reports, while three publishers (Inderscience, PLOS and Springer Nature) referred to the COPE guidelines. Originality/value No such Twitter-based case has yet been examined in detail in the publishing ethics literature. 


#PubPeer #RetractionWatch #Enron #uBiome


https://www.researchgate.net/publication/333890188_A_new_dimension_in_publishing_ethics_social_media-based_ethics-related_accusations





Comments

Post a Comment

Popular posts from this blog

Interview of Elisabeth Bik – Scientific Editorial Director at uBiome

Image
"uBiome is the leader in microbial genomics. We develop microbiome products for both consumers as well as for patients and clinicians.  We have developed two clinical products, SmartGut for gastrointestinal conditions, and SmartJane, which combines vaginal microbiome analysis with STI and HPV genotyping. These clinical products are clinician-prescribed and are reimbursable by most health insurance companies." Elisabeth Bik
Read more

Expression of Concern on article published by uBiome / PubPeer scientist Elisabeth Bik

Image
Concerns were raised about the origin of stool samples used to generate the microbiome dataset. Specifically, concerns were raised about the possible inclusion of samples from participants affected by health conditions or antibiotic usage, and non-humans. The first author has stated that an audit of customer service data held at uBiome in August 2019 identified information indicating that one of the samples submitted by a uBiome user, and labelled as a human gut sample, may have had a non-human origin.
Read more

The troll Leonid Schneider & ‘For Better Science’: crank or cure?

Image
I’ve been aware of Leonid Schneider’s expose blog ever since the piece on the supposed  fraud of Nobel prize-winner Gregg Semenza  appeared on my Twitter feed. Schneider portrays himself as an  under-dog ; the self-styled “ failed scientist ” has taken a liking to pillaring the hypocrisies of the scientific establishment. To be honest, although criticisms of the undertakings of science are always needed, especially when it concerns matters of data integrity, publishing practices, and perverse incentives in academia, I am a bit weary of uncritically listening to someone who appears to have no established career in either science or science journalism (the only pieces published under his own name appear only on the blog he runs). And his pieces do come off with a bit of crankiness.
Read more